ArticleDisease models & mechanisms2019

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.

Sangeetha Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.